Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer

European Journal of Radiology

Volumn 83, Issue 7, 2014, Pages 1169-1176

  Miccò, Maura ^a   Vargas, Hebert Alberto ^a   Burger, Irene A ^a   Kollmeier, Marisa A ^a   Goldman, Debra A ^a   Park, Kay J ^a   Abu Rustum, Nadeem R ^a   Hricak, Hedvig ^a   Sala, Evis ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cervical cancer; DWI; MRI; PET CT; Quantitative parameters; Survival

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER; YOUNG ADULT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84902287879     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.03.024     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J Clin 63 1 2013 11 30
2. J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, W.T. Creasman, and A.P. Heintz et al. Carcinoma of the cervix uteri J Epidemiol Biostat 6 1 2001 7 43
3. M.G. Thomeer, C. Gerestein, S. Spronk, H.C. van Doorn, E. van der Ham, and M.G. Hunink Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis Eur Radiol 23 7 2013 2005 2018
4. N.A. Mayr, W.T. Yuh, D. Jajoura, J.Z. Wang, S.S. Lo, and J.F. Montebello et al. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer Cancer 116 4 2010 903 912
5. F. Kuang, J. Ren, Q. Zhong, F. Liyuan, Y. Huan, and Z. Chen The value of apparent diffusion coefficient in the assessment of cervical cancer Eur Radiol 23 4 2013 1050 1058
6. G.S. Payne, M. Schmidt, V.A. Morgan, S. Giles, J. Bridges, and T. Ind et al. Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer Gynecol Oncol 116 2 2010 246 252
7. Y. Liu, R. Bai, H. Sun, H. Liu, and D. Wang Diffusion-weighted magnetic resonance imaging of uterine cervical cancer J Comput Assist Tomogr 33 6 2009 858 862
8. P.Z. McVeigh, A.M. Syed, M. Milosevic, A. Fyles, and M.A. Haider Diffusion-weighted MRI in cervical cancer Eur Radiol 18 5 2008 1058 1064
9. Y. Liu, Z. Ye, H. Sun, and R. Bai Grading of uterine cervical cancer by using the ADC difference value and its correlation with microvascular density and vascular endothelial growth factor Eur Radiol 23 3 2013 757 765
10. mean) on primary cervical cancer is a predictive marker for disease recurrence Gynecol Oncol 127 3 2012 478 483
11. Y. Liu, R. Bai, H. Sun, H. Liu, X. Zhao, and Y. Li Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation Clin Radiol 64 11 2009 1067 1074
12. H.S. Kim, C.K. Kim, B.K. Park, S.J. Huh, and B. Kim Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging J Magn Reson Imaging 37 1 2013 187 193
13. G. Somoye, V. Harry, S. Semple, G. Plataniotis, N. Scott, and F.J. Gilbert et al. Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation Eur Radiol 22 11 2012 2319 2327
14. C. Onal, M. Reyhan, C. Parlak, O.C. Guler, and E. Oymak Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy Int J Gynecol Cancer 23 6 2013 1104 1110
15. S.M. Larson, Y. Erdi, T. Akhurst, M. Mazumdar, H.A. Macapinlac, and R.D. Finn et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis Clin Positron Imag Off J Inst Clini PET 2 3 1999 159 171
16. F.Y. Liu, A. Chao, C.H. Lai, H.H. Chou, and T.C. Yen Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma Gynecol Oncol 125 3 2012 566 571
17. H.H. Chung, J.W. Kim, K.H. Han, J.S. Eo, K.W. Kang, and N.H. Park et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer Gynecol Oncol 120 2 2011 270 274
18. H.H. Chung, H.W. Kwon, K.W. Kang, N.H. Park, Y.S. Song, and J.K. Chung et al. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer Ann Surg Oncol 19 6 2012 1966 1972
19. J. Yoo, J.Y. Choi, S.H. Moon, D.S. Bae, S.B. Park, and Y.S. Choe et al. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography Int J Gynecol Cancer 22 7 2012 1226 1233
20. C. Crivellaro, M. Signorelli, L. Guerra, E. De Ponti, A. Buda, and C. Dolci et al. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer Gynecol Oncol 127 1 2012 131 135
21. B.E. Akkas, B.B. Demirel, A. Dizman, and G.U. Vural Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer? Ann Nucl Med 27 October (8) 2013 756 763 10.1007/s12149-013-0745-1
22. Y.E. Erdi, O. Mawlawi, S.M. Larson, M. Imbriaco, H. Yeung, and R. Finn et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 12 Suppl. 1997 2505 2509
23. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, and R. Ford et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2 2009 228 247
24. F. Xue, L.L. Lin, F. Dehdashti, T.R. Miller, B.A. Siegel, and P.W. Grigsby F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 1 2006 147 151
25. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 8 2007 1738 1744
26. H.H. Chung, B.H. Nam, J.W. Kim, K.W. Kang, N.H. Park, and Y.S. Song et al. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer Eur J Nucl Med Mol Imag 37 8 2010 1467 1473
27. min of the primary tumour is a predictor of prognosis in patients with cervical cancer Eur J Nucl Med Mol Imag 39 2 2012 283 290
28. E.A. Kidd, B.A. Siegel, F. Dehdashti, J.S. Rader, D.G. Mutch, and M.A. Powell et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 12 2010 2108 2113
29. O.F. Donati, D. Chong, D. Nanz, A. Boss, J.M. Froehlich, and E. Andres et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients Radiology 270 2 2014 454 463
30. S.I. Semple, V.N. Harry, D.E. Parkin, and F.J. Gilbert A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 75 2 2009 611 617